22.06.2022 • NewsAzelisIndustrial ChemicalsLife Sciences

Azelis Takes Majority Share of ROCSA Colombia

Azelis has agreed to acquire a majority stake in ROCSA Colombia, a specialty chemical distributor serving the life sciences and industrial chemical markets in South America.

Financial terms of the transaction, which is expected to close in the third quarter of 2022, were not disclosed.

Headquartered in Bogota, the company is one of Colombia’s leading specialty chemical distributors and is also present in Peru and Central America. It has over 130 employees, serving more than 1,900 customers in markets that include food & nutrition, personal care, home care & industrial cleaning, coatings, adhesives, sealants and elastomers (CASE) and plastic additives.

“Our market-leading regional expertise together with Azelis’ strong global network brings us a powerful international reach, which will benefit our diverse range of principals and customers,” said ROCSA’s CEO, Carlos Yaipen. “We look forward to leveraging Azelis’ leadership in sustainability, digitalization and innovation, and we’re confident that ROCSA will thrive under Azelis’ ownership.”

Azelis said the addition of ROCSA’s portfolio of products and capabilities is a significant milestone in its strategy in South America. Earlier this month, the multinational distribution group opened a new headquarters in Mexico City, the latest in a series of major developments in Mexico over the past few years to grow its operations in Latin America.

Author: Elaine Burridge, Freelance Journalist

© azelis
© azelis

Company

Logo:

Azelis Corporate Services NV

12 box 6, Posthofbrug
2600 Antwerpen
Belgium

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.